Duopharma Seeking To Diversify Manufacturing Domain

Leonard Ariff Abdul Shatar, Group Managing Director, Duopharma Biotech

13-Mar-24 08:00

Duopharma Seeking To Diversify Manufacturing Domain

Pause
Embed

Malaysian pharmaceutical Duopharma Biotech achieved their best financial performance to date in 2022, reaching record highs for revenue and profit. However 2023 was not as kind, with profit after tax falling by 25% despite top line growth. How are they looking to reverse course in 2024? We discuss strategy with Group Managing Director Leonard Ariff Abdul Shatar.

Produced by: Chin Wai Lun

Presented by: Shazana Mokhtar

This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.

Categories: sponsored content, medical advances, managing

Tags: duopharma biotech, pharmaceuticals, market growth,

Today’s Shows

11:00 AM

Best of Enterprise

(REPEAT) We unpack the complexities of CEO succession, especially in founder-led or family-run companies that dominate Malaysia’s corporate landscape.

12:00 PM

Popcorn Culture

(REPEAT) We review season 2 of Andor and talk about the value of binge watching versus savouring episodes on a week to week basis.

1:00 PM

Cruise Control

(REPEAT) What’s cool at The Malaysia Autoshow 2025? Join us as we share some of the highlights!

2:00 PM

Matt-Splained

(REPEAT) Rich and Matt pay tribute to Gen X and reflect on simpler times.

3:00 PM

Earth Matters

(REPEAT) We explore the troubling trade behind songbird competitions and their threats to our ecosystem.

4:00 PM

Bar None

(REPEAT) It’s squat, bench and deadlift on this episode of Bar None as we speak to Kenneth Kaden Chin, a powerlifter and the Deputy President of the Malaysian Association for Powerlifting.

5:00 PM

BBC World Service

BFM presents the BBC World Service, which provides in-depth coverage of issues from around the world.

PROGRAMMES